Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/43814
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: Role of p53 in irinotecan-induced intestinal cell death and mucosal damage
Author: Bowen, J.
Gibson, R.
Stringer, A.
Chan, T.
Prabowo, A.
Cummins, A.
Keefe, D.
Citation: Anti-Cancer Drugs, 2007; 18(2):197-210
Publisher: Lippincott Williams & Wilkins
Issue Date: 2007
ISSN: 0959-4973
1473-5741
Statement of
Responsibility: 
Bowen, Joanne M.; Gibson, Rachel J.; Stringer, Andrea M.; Chan, Thong W.; Prabowo, Avanita S.; Cummins, Adrian G.; Keefe, Dorothy M.K.
Abstract: Irinotecan treatment of colorectal cancers results in high-grade intestinal mucositis in a large proportion of patients. The mechanisms behind irinotecan-induced mucosal injury, however, have yet to be fully explained. The aim of this study was to investigate the role of the p53 protein in the onset of intestinal damage following irinotecan treatment in two different settings. IEC-6 and FHs 74 intestinal cell lines were treated with irinotecan with and without a temporary p53 inhibitor, pifithrin-alpha, and examined for changes in proliferation and survival along with expression of p53 and related proteins. Forty tumour-bearing rats also underwent irinotecan treatment with and without pifithrin-alpha, and the effects on intestinal morphology, gene expression, apoptosis and other toxicities were assessed. Irinotecan caused a dose-dependent reduction in cell viability that was not prevented by pifithrin-alpha in either cell line. Rats responded to irinotecan with diarrhoea, weight loss, histopathological changes to the small and large intestine, increased crypt apoptosis, and a mild inflammatory response. Pifithrin-alpha reduced severity and duration of intestinal apoptosis; however, it did not significantly affect other parameters including p53 expression. Temporary inhibition of p53 activation does not markedly prevent intestinal cell death or mucositis following irinotecan treatment. Irinotecan may act through upregulation of proapoptotic proteins Bax and Bak to induce cell death.
Keywords: Intestinal Mucosa; Colon; Cell Line; Cell Line, Tumor; Epithelial Cells; Animals; Rats; Toluene; Camptothecin; Proliferating Cell Nuclear Antigen; Antineoplastic Agents, Phytogenic; Blotting, Western; Cell Count; Immunohistochemistry; Cell Adhesion; Cell Death; Apoptosis; Cell Survival; Gene Expression Regulation, Neoplastic; Genes, bcl-2; Female; Tumor Suppressor Protein p53; Cyclin-Dependent Kinase Inhibitor p21; Benzothiazoles; Irinotecan
Description: Copyright © 2007 Lippincott Williams & Wilkins, Inc.
RMID: 0020070095
DOI: 10.1097/CAD.0b013e328010ef29
Published version: http://www.anti-cancerdrugs.com/pt/re/anticd/abstract.00001813-200702000-00011.htm
Appears in Collections:Medicine publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.